Overview | Published:

NF-κB is 25

Nature Immunology volume 12, pages 683685 (2011) | Download Citation

NF-κB-mediated inflammatory biology can be formulated as the following five states: latency, induction, response, resolution and pathology. The first four involve carefully tuned molecular processes; pathology is the loss of control.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Multiple nuclear factors interact with the immunoglobulin enhancer sequences. J. Immunol. 177, 7485–7496 (2006).

  2. 2.

    Origin and physiological roles of inflammation. Nature 454, 428–435 (2008).

  3. 3.

    Hierarchies of NF-κB target-gene regulation. Nat. Immunol. 12, 689–694 (2011).

  4. 4.

    , & Crosstalk in NF-κB signaling pathways. Nat. Immunol. 12, 695–708 (2011).

  5. 5.

    , & One nucleotide in a kB site can determine cofactor specificity for NF-κB dimers. Cell 118, 453–464 (2004).

  6. 6.

    The origins of NF-κB. Nat. Immunol. 12, 686–688 (2011).

  7. 7.

    , , & The IκB-NF-κB signaling module: temporal control and selective gene activation. Science 298, 1241–1245 (2002).

  8. 8.

    et al. Oscillations in NF-κB signaling control the dynamics of gene expression. Science 306, 704–708 (2004).

  9. 9.

    & The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat. Immunol. 10, 281–288 (2009).

  10. 10.

    Return to homeostasis: downregulation of NF-κB responses. Nat. Immunol. 12, 709–714 (2011).

  11. 11.

    et al. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 289, 2350–2354 (2000).

  12. 12.

    , , & NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103, 12481–12486 (2006).

  13. 13.

    et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208, 1189–1201 (2011).

  14. 14.

    et al. NF-κB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc. Natl. Acad. Sci. USA 108, 9814–9819 (2011).

  15. 15.

    & Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 12, 715–723 (2011).

Download references

Author information

Affiliations

  1. Division of Biology, California Institute of Technology, Pasadena, California, USA.

    • David Baltimore

Authors

  1. Search for David Baltimore in:

Competing interests

The author declares no competing financial interests.

Corresponding author

Correspondence to David Baltimore.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/ni.2072

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing